Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Current COVID-19 pandemic poses an unprecedented threat to global health and healthcare systems. The most amount of the death toll is accounted by old people affected by age-related diseases that develop a hyper-inflammatory syndrome. In this regard, we hypothesized that COVID-19 severity may be lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbatinelli, Jacopo, Giuliani, Angelica, Matacchione, Giulia, Latini, Silvia, Laprovitera, Noemi, Pomponio, Giovanni, Ferrarini, Alessia, Svegliati Baroni, Silvia, Pavani, Marianna, Moretti, Marco, Gabrielli, Armando, Procopio, Antonio Domenico, Ferracin, Manuela, Bonafè, Massimiliano, Olivieri, Fabiola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722494/
https://www.ncbi.nlm.nih.gov/pubmed/33307107
http://dx.doi.org/10.1016/j.mad.2020.111413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722494/
https://www.ncbi.nlm.nih.gov/pubmed/33307107
http://dx.doi.org/10.1016/j.mad.2020.111413

Ejemplares similares